集采药品“三进”落地：成效初显下堵点待解

Core Viewpoint - The acceleration of the "last mile" in centralized drug procurement is enhancing accessibility and convenience for the public, promoting the healthy development of the pharmaceutical industry, and facilitating the downward flow of medical resources [1][2]. Group 1: Policy Implementation - The National Medical Insurance Administration has encouraged grassroots medical institutions, private medical facilities, and retail pharmacies to participate in centralized procurement, laying the foundation for extending drug procurement to grassroots levels [1]. - Jiangxi Province has taken the lead in implementing the "Three Advances" initiative, which aims to integrate centralized procurement into retail pharmacies, private medical institutions, and village health clinics [1][3]. - Other provinces such as Zhejiang, Guangdong, and cities like Datong have followed suit, expanding the scope of the policy [1][3]. Group 2: Impact and Effectiveness - As of September 30, 2025, the coverage rate of voluntarily participating grassroots medical institutions, private medical institutions, and retail pharmacies in Jiangxi reached 73.6%, with significant increases in the number of covered products, procurement volume, and monetary value [2][3]. - The introduction of centralized procurement has reduced patient medication costs, as prices are generally lower, leading to a decrease in overall drug prices in the market [2][3]. Group 3: Market Activation - The "Three Advances" initiative is revitalizing the grassroots drug market, providing new opportunities and challenges for pharmaceutical companies [5]. - Pharmaceutical companies are required to adjust production scales and product structures to meet the diverse needs of different medical institutions and ensure timely supply to grassroots facilities and retail pharmacies [5]. Group 4: Challenges and Barriers - Despite progress, experts highlight several barriers to effective implementation, including insufficient execution by some medical institutions and a lack of motivation among retail pharmacies due to inadequate compensation mechanisms [8][9]. - The current design of the "Three Advances" policy primarily focuses on expanding market share for winning bidders without adequately addressing the operational challenges faced by private hospitals and pharmacies [9].